医学
电针
颈椎病
临床试验
物理疗法
针灸科
协议(科学)
可视模拟标度
颈部疼痛
物理医学与康复
随机对照试验
不利影响
颈椎
康复
心理干预
吞咽困难
肌电图
最小临床重要差异
颈部神经根病变
神经根痛
梅德林
鞭击
研究设计
临床研究设计
外科
作者
Debiao Yu,Fa Lin,Peng Chen,Zeng Jinfan,Wu Lin,Bin Shao
出处
期刊:Pain management
[Future Medicine]
日期:2026-10-30
卷期号:: 1-14
标识
DOI:10.1080/17581869.2026.2754349
摘要
BACKGROUND: Painful cervical radiculopathy due to cervical spondylosis (painful CSR) is characterized by radicular pain and neurological dysfunction. Conservative care commonly includes medication and physical therapy, but evidence for individual nonsurgical interventions remains uncertain. Electroacupuncture (EA) is a non-pharmacological option, but rigorous sham-controlled evidence in painful CSR remains limited. This trial aims to compare the complete EA protocol with the selected SEA protocol and to characterize accompanying changes in prespecified cervical biomechanical measures. METHODS/DESIGN: This single-center, randomized, sham-controlled trial will enroll 80 participants with painful CSR and randomly assign them 1:1 to EA or SEA. Participants, outcome assessors, and the data analyst will be blinded. Both groups will receive identical standardized common care, with EA or SEA delivered in 20 sessions over 4 weeks, followed by 24 weeks of post-treatment follow-up. The primary outcome is the Week-4 Visual Analog Scale (VAS) score, analyzed with adjustment for baseline VAS. Supportive key secondary outcomes are the Week-4 Neck Disability Index (NDI) and Week-4 mean resting upper-trapezius shear-wave speed (SWS) on the primary symptomatic side. Other secondary outcomes include ultrasound- and surface electromyography (sEMG)-derived biomechanical measures, Patient Global Impression of Change (PGIC), rescue-medication use, and the Short Form Health Survey (SF-36). Adverse events will be recorded through Week 28. DISCUSSION: This trial will estimate the comparative clinical effects of the complete EA protocol relative to the selected SEA protocol and assess whether prespecified cervical biomechanical measures change alongside clinical outcomes. The findings may inform future evaluation of EA as a non-pharmacological treatment for painful CSR. CLINICAL TRIAL REGISTRATION: The Chinese Clinical Trial Registry identifier is ChiCTR2300075726.
科研通智能强力驱动
Strongly Powered by AbleSci AI